Vtama (tapinarof) — Highmark
Atopic dermatitis
Initial criteria
- age ≥ 2 years
- diagnosis of atopic dermatitis (ICD-10: L20)
- experienced therapeutic failure, contraindication, or intolerance to one of the following: topical tacrolimus OR topical pimecrolimus
Reauthorization criteria
- prescriber attests that the member has experienced positive clinical response to therapy